Why does science direct say this?
"
19-NT has been shown to suppress LH and FSH effectively with full maintenance of androgen-dependent functions. With the combination of both androgenic and progestational activity, the potential for 19-NT to provide contraception as a single agent has been considered. Small trials with 19-NT alone or in combination with depot medroxyprogesterone acetate (DMPA, see below) have confirmed that azoospermia is induced without any symptoms of androgen deficiency (despite low T levels)."
Anyway i'm not advocating for deca only. i just haven't found any study on why nandrolone, a male sex hormone, would cause impotence. i understand that the common answer is nandrolone is a less androgenic drug but a lot of AAS(winstrol, mast, proviron, drol, dbol) are less androgenic than Test on paper.
There are always sources of disagreement among studies that investigate matters that are not taught as subject matter in textbooks (so called theories, that are well-supported and reasoned constructs that explain some phenomenon). Basically, when it comes to uncertain hypotheses (those worthy of funding & scientific work for investigation), you'll always find uncertainty in the results, and eventually there will arise what may be fairly considered as exceptions to the general rule in the recent literature (remember the axiom of what the exception does to the rule).
Similarly, there are inconsistent findings with MENT supporting sexual function. Small studies (often n<10 subjects) might show it fully supports sexual function and libido. Others, the opposite. From Walton & colleagues (doi:10.2164/jandrol.107.002683), 2 of 13 (15%) MENT subjects withdrew after 8 weeks of treatment due to low libido & erectile dysfunction...Adverse events included reduced libido & erectile function in 4 *additional* subjects in the MENT group who completed treatment (6/13, or 46%) [these adverse effects were not reported by any subject in the testosterone group]...Due to the incidence of reports of low libido and early withdrawal in the MENT group, it was decided in consultation with the study Data Monitoring and Safety Committe to shorten the MENT treatment period to 24 weeks whereas men in the testosterone group completed 48 weeks of treatment.
My view (a hypothesis supported by the bulk of the literature; a construct), is that 5α-reductase amplification (e.g., T ⇒ E₂) is a discrete function (similar to aromatization) of testosterone. That modern synthetic AAS fail (the bulk of work in synthesis thereof having ended in the 1960s for all intents and purposes), without T. Hypothetically, other androgens may conceivably be designed that amplify androgenic action in the 5α-reductase rich gonadal tissues; e.g., Halo may, but its 5α-reductase product has never been investigated to either confirm or refute whether its action is amplified or is merely sufficiently androgenic to serve as a satisfactory therapy in sexual dysfunction due to androgen deprivation (e.g., TRT). Actually, come to think of it, 1-Testosterone ("DHB") fits this criteria, acting ostensibly as a prohormone to DHT. Peter Bond thinks that 1-Testo metabolizes to DHT perhaps by some unknown enzyme that subjects 1-Test to 1,2-dihydrogenation during its metabolism. The only plausible other explanation I've been able to think of is that perhaps this occurs by inhibition of 17β-HSD1 (thereby increasing DHT & lowering E₂), and there is some support from modeling of inhibitors of 17β-HSD.
I believe that an AAS must be profoundly androgenic (e.g., metandienone [Dbol]) to sufficiently overcome a lack of 5α-reductase amplification, and that only T can
reliably (the exception proving the rule; of course some weirdos may report a libido
increase on Deca only, but it would be very unusual) support sexual function as a general rule.
Deca dosed at 600 mg/w is the lowest dose that can plausibly support sexual function, and bloodwork supports its yielding low-normal E₂ (see
Nandrolone Data (including joint pain relief mechanisms [by Type-IIx]); this would tend to line up with the basal potency of DHN in those 5α-reductase rich gonadal tissues.
The fact that well into supra-physiologic dosing & resultant concentrations of Deca is required to adequately support sexual function bolsters my view or hypothesis.
Proviron is yet another, albeit interesting, exception, in that it augments libido and sexual drive by acting on the brain & CNS. Electroencephalographic profiles of varying dosages of mesterolone (as low as 1 mg) were found to be very similar to those seen with psychostimulants such as dextroamphetamine (a well known potent stimulator of sexual behavior in animals including humans). In this regard, it acts oppositely Deca as well.